Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dextroamphetamine sulfate
Drug ID BADD_D00637
Description Dextroamphetamine is the dextrorotary enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Indications and Usage Used to treat attention deficit hyperactivity disorder (ADHD).
Marketing Status Prescription; Discontinued
ATC Code N06BA02
DrugBank ID DB01576
KEGG ID D02078
MeSH ID D003913
PubChem ID 5825
TTD Drug ID D0T3LF
NDC Product Code 24338-855; 0406-8958; 63629-2374; 24338-856; 75826-125; 0115-9927; 11534-188; 24338-852; 64896-674; 13107-036; 13107-035; 0406-8961; 45963-304; 43386-870; 43386-871; 51862-346; 0555-0952; 24338-853; 10702-065; 75826-121; 75826-120; 52536-510; 0115-9928; 52536-500; 24338-850; 51634-0222; 0115-9929; 11014-0322; 68382-944; 75826-126; 61960-0210; 51862-345; 11014-0323; 45963-303; 0406-8960; 51862-344; 0555-0953; 0406-8962; 52536-520; 64896-675; 68382-941; 0406-8959; 52536-530; 68382-942; 75826-124; 24338-851; 68382-943; 11534-189; 68382-945; 11014-0324; 45963-305; 10702-066; 66993-359; 49812-0058; 24338-854; 63629-2375; 21724-701; 75826-123; 75826-122; 0406-1950; 64896-673; 52536-515; 65392-0114
Synonyms Dextroamphetamine | Dexamphetamine | Dexamfetamine | dextro-Amphetamine | dextro Amphetamine | d-Amphetamine | d Amphetamine | Dexedrine | DextroStat | Oxydess | Curban | Dextroamphetamine Sulfate | Sulfate, Dextroamphetamine | Dextro-Amphetamine Sulfate | Dextro Amphetamine Sulfate | d-Amphetamine Sulfate | d Amphetamine Sulfate
Chemical Information
Molecular Formula C18H28N2O4S
CAS Registry Number 51-63-8
SMILES CC(CC1=CC=CC=C1)N.CC(CC1=CC=CC=C1)N.OS(=O)(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Mental disability26.01.01.001--Not Available
Mental impairment19.21.02.003; 17.03.03.002--Not Available
Mood swings19.04.03.001--Not Available
Mydriasis17.02.11.003; 06.05.03.004--Not Available
Myocardial infarction24.04.04.009; 02.02.02.007--
Nausea07.01.07.001--
Nervous system disorder17.02.10.001--Not Available
Nervousness19.06.02.003--Not Available
Neuroleptic malignant syndrome15.05.04.015; 12.03.01.003; 08.05.01.005; 17.05.02.003--Not Available
Pallor24.03.04.001; 23.03.03.031; 08.01.03.032--Not Available
Palpitations02.01.02.003--
Panic attack19.06.04.001--Not Available
Panic reaction19.06.04.003--Not Available
Paranoia19.05.01.005--Not Available
Polyuria20.02.03.002--Not Available
Psychomotor retardation19.15.02.002--Not Available
Rash23.03.13.001--Not Available
Restlessness19.11.02.002; 17.02.05.021--
Rhabdomyolysis15.05.05.002--
Seizure17.12.03.001--
Shock24.06.02.002--Not Available
Skin disorder23.03.03.007--Not Available
Sleep terror19.02.03.008; 17.15.02.006--Not Available
Sudden death02.03.04.013; 08.04.01.003--
Syncope24.06.02.012; 17.02.04.008; 02.01.02.008--
Tachycardia02.03.02.007--Not Available
Tension19.06.02.005--Not Available
Tic19.11.04.001; 17.02.05.024--Not Available
Tourette's disorder19.11.04.002; 17.19.02.001; 03.10.01.001--Not Available
Tremor17.01.06.002--
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages